NMD Pharma
PrivateLast Round
Series B
Extension
Nov 15, 2023
Total Funding Raised
$171M
Momentum Score
50 /100
Company Overview
NMD Pharma is a biotechnology company developing a first-in-class platform of small molecule therapies for the treatment of severe neuromuscular disorders.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NMD Pharma Comps
Public and private peers based on sector, stage, and business model.
NMD Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Nov 15, 2023 | ||||
| Series B | Feb 15, 2022 | ||||
| Series A | Mar 23, 2018 | ||||
| Seed | Jun 2, 2016 |
Key People
Founding team and executive leadership
NMD Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeck Foundation | Series B |
| Lundbeckfonden BioCapital | Series B Extension |
| Novo Seeds | Seed, Series A |
| Roche Venture Fund | Series B Extension, Series A, Series B |
| Novo Holdings | Series B Extension, Series B |
| Lundbeck | Series B Extension, Series A, Series B |
| Inkef Capital | Series B Extension, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
Presented SYNAPSE-CMT study data at the MDA Conference.
- Mar 10, 2026
Top-line safety and efficacy data released for ignaseclant in Phase 2a study.
NMD Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NMD Pharma's valuation, stock price, and market status.
